Developing the clinical components of a complex intervention for a glaucoma screening trial: A mixed methods study

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Burr, Jennifer M ^a   Campbell, Marion K ^a   Campbell, Susan E ^a   Francis, Jillian J ^a   Greene, Alexandra ^a   Hernández, Rodolfo ^a   Hopkins, Debra ^a   McCann, Sharon K ^a   Vale, Luke D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLINDNESS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; HUMAN; INTERVIEW; MASS SCREENING; METHODOLOGY; OPEN ANGLE GLAUCOMA; PHYSICIAN; VISION TEST;

BLINDNESS; COST-BENEFIT ANALYSIS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTERVIEWS AS TOPIC; MASS SCREENING; PHYSICIANS; VISION TESTS;

EID: 79958851290     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-54     Document Type: Article

References (35)

1. Developing and evaluating complex interventions: the new Medical Research Council guidance. P Craig P Dieppe S Macintyre S Michie I Nazareth M Petticrew, Br Med J 2008 337 1655 10.1136/bmj.a1655
2. The number of people with glaucoma worldwide in 2010 and 2020. HA Quigley AT Broman, Br J Ophthalmol 2006 90 3 262 7 10.1136/bjo.2005.081224 16488940 (Pubitemid 43325451)
3. Leading causes of certification for blindness and partial sight in England & Wales. C Bunce R Wormald, BMC Public Health 2006 6 58 7 16409623
4. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. P Maier J Funk G Schwarzer G Antes Y Falck-Ytter, BMJ 2005 331 7509 134 10.1136/bmj.38506.594977.E0 15994659
5. Medical interventions for primary open angle glaucoma and ocular hypertension. C Vass C Hirn T Sycha O Findl P Bauer L Schmetterer, Cochrane Database of Systematic Reviews 2007 4 003167
6. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. JM Burr G Mowatt R Hernndez MA Siddiqui J Cook T Lourenco C Ramsay L Vale C Fraser A Azuara-Blanco J Deeks J Cairns R Wormald S McPherson K Rabindranath A Grant, Health Technol Assess 2007 x x 1-190; Oct;11(41).
7. Why Do Some People Go Blind from Glaucoma. W Grant J Burke, Ophthalmology 1982 89 991 8 7177577 (Pubitemid 12001626)
8. Blindness in patients with treated open-angle glaucoma. PP Chen, Ophthalmology 2003 110 4 726 33 10.1016/S0161-6420(02)01974-7 12689894 (Pubitemid 36520071)
9. Risk factors for late presentation in chronic glaucoma. S Fraser C Bunce R Wormald, Invest Ophthalmol Vis Sci 1999 40 10 2251 7 10476790 (Pubitemid 29418379)
10. ReGAE 2 glaucoma awareness and the primary eye-care service: some perceptions among African Caribbeans in Birmingham UK. V Cross P Shah R Bativala P Spurgeon, Eye 2007 21 7 912 20 10.1038/sj.eye.6702461 16902494 (Pubitemid 47062072)
11. Knowledge and beliefs about common eye diseases. K Attebo P Mitchell R Cumming W Smith, Australian & New Zealand Journal of Ophthalmology 1997 25 4 283 7 21516537 (Pubitemid 27501776)
12. Screening for glaucoma. Why is the disease underdetected? MW Tuck RP Crick, Drugs & Aging 1997 10 1 1 9 [Review] 10.2165/00002512-199710010-00001 21516518 (Pubitemid 27057933)
13. A prospective survey to determine sources and diagnostic accuracy of glaucoma referrals. GP Brittain DJ Austin SP Kelly, Health Trends 1988 20 2 43 4 10288506
14. Outcomes of referrals by community optometrists to a hospital glaucoma service. B Bowling SD Chen JF Salmon, Br J Ophthalmol 2005 89 9 1102 4 10.1136/bjo.2004.064378 16113358 (Pubitemid 41224453)
15. Accuracy of referral to a glaucoma clinic. RW Bell C O'Brien, Ophthalmic & Physiological Optics 1997 17 1 7 11 10.1111/j.1475-1313.1997.tb00517.x 21516460 (Pubitemid 27037688)
16. criteria for appraising the viability, effectiveness and appropriateness of a screening programme. Programme appraisal criteria, 2010 http://www.screening.nhs.uk/criteria
17. the UK NSC policy on glaucoma screening in adults. Glaucoma, 2010 http://www.screening.nhs.uk/glaucoma
18. Screening for prevention of optic nerve damage due to chronic open angle glaucoma. S Hatt R Wormald J Burr, Cochrane Database of Systematic Reviews 2006 4 006129
19. National Institute for Clinical Excellence, Guide to the methods of technology appraisal London: NICE 2008
20. Economic evaluation of screening for open-angle glaucoma. RA Hernndez JM Burr LD Vale OAG Screening Project Group, Int J Technol Assess Health Care 2008 24 2 203 11 18400124 (Pubitemid 351519520)
21. Cost effectiveness and cost utility of an organized screening programme for glaucoma. H Vaahtoranta-Lehtonen A Tuulonen P Aronen H Sintonen L Suoranta N Kovanen, Acta Ophthalmol Scand 2007 85 5 508 18 10.1111/j.1755-3768.2007.00947. x 17655612 (Pubitemid 47163112)
22. Glaucoma: an area of darkness. RA Hitchings, Eye (Lond) 2009 23 9 1764 74
23. Screening for primary open-angle glaucoma in the primary care setting: an update for the US preventive services task force. C Fleming EP Whitlock T Beil B Smit RP Harris, Annals of Family Medicine 2005 3 2 167 70 10.1370/afm.293 15798044 (Pubitemid 40477703)
24. Population screening for primary open-angle glaucoma (Structured abstract). B Cote N Rodriguez, Montreal: Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS) 2007
25. Glaucoma: screening and early diagnosis - problems and outlook in France. Haute Autorite de Sante (French National Authority for Health), Paris: Haute Autorite de Sante (French National Authority for Health) (HAS) 2007
26. Screening tests for detecting open-angle glaucoma: systematic review and meta-analysis. G Mowatt JM Burr JA Cook MA Siddiqui C Ramsay C Fraser, Invest Ophthalmol Vis Sci 2008 49 12 5373 85 10.1167/iovs.07-1501 18614810
27. Vision 2020 UK: the right to sight, http://www.vision2020uk.org.uk/
28. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? RS Barbour, BMJ 2001 322 1115 17 10.1136/bmj.322.7294.1115 11337448 (Pubitemid 32411191)
29. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group MO Gordon V Torri S Miglior JA Beiser I Floriani JP Miller F Gao I Adamsons D Poli RB D'Agostino MA Kass, Ophthalmology 2007 114 1 10 9 17095090
30. Principles and practice of screening for disease, Geneva: WHO, http://whqlibdoc.who.int/php/WHO-PHP-34.pdf
31. The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. S Philip AD Fleming KA Goatman S Fonseca P McNamee GS Scotland, Br J Ophthalmol 2007 91 11 1512 7 10.1136/bjo.2007.119453 17504851 (Pubitemid 350044057)
32. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. GS Scotland P McNamee S Philip AD Fleming KA Goatman GJ Prescott S Fonseca PF Sharp JA Olson, Br J Ophthalmol 2007 91 11 1518 23 10.1136/bjo.2007.120972 17585001 (Pubitemid 350044058)
33. Intelligent fusion of cup-to-disc ratio determination methods for glaucoma detection in ARGALI. DW Wong J Liu JH Lim NM Tan Z Zhang S Lu, Conference Proceedings:.Annual International Conference of the IEEE Engineering in Medicine & Biology Society 2009 2009 5777 80 21438186
34. Response rates in postal surveys of healthcare professionals between 1996 and 2005: An observational study. J Cook H Dickinson M Eccles, BMC Health Services Research 2009 9 1 160 10.1186/1472-6963-9-160 19751504
35. Multidisciplinary, interdisciplinary, or dysfunctional? Team working in mixed-methods research. A O'Cathain E Murphy J Nicholl, Qual Health Res 2008 18 11 1574 85 10.1177/1049732308325535 18849518